EUVIMEDEUVIMED entdecken
Open Access

Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up

Christian Ekanger iD, Svein Inge Helle, Lars Reisæter, Liv Bolstad Hysing iD, Rune Kvåle iD, Alfred Honoré iD, Karsten Gravdal iD, Sara Pilskog, Olav Dahl

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.23.01391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Christian Ekanger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Salvage Therapy, Neoplasm Recurrence, Local, Re-Irradiation. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE There are no well-established re-treatment options for local recurrence after primary curative radiation therapy for prostate cancer (PCa), as prospective studies with long-term follow-up are lacking. Here, we present results from a prospective study on focal salvage reirradiation with external-beam radiation therapy with a median follow-up of 7.2 years. MATERIALS AND METHODS From 2013 to 2017, 38 patients with biopsy-proven locally recurrent PCa >2 years after previous treatment and absence of grade 2-3 toxicity from the first course of radiation were included. The treatment was 35 Gy in five fractions to the MRI-based target volume and 6 months of androgen-deprivation therapy starting 3 months before radiation. The Phoenix criteria defined biochemical recurrence-free survival (bRFS), and toxicity was scored according to Radiation Therapy Oncology Group criteria. RESULTS Median age was 70 years, and median time from primary radiation to prostate-specific antigen (PSA) recurrence was 83 months. The actuarial 2-year and 5-year bRFS were 81% (95% CI, 69 to 94) and 58% (95% CI, 49 to 74), respectively. The actuarial 5-year local recurrence-free survival was 93% (95% CI, 82 to 100), metastasis-free survival was 82% (95% CI, 69 to 95), and overall survival was 87% (95% CI, 76 to 98). Two patients (5%) had durable grade 3 genitourinary toxicity, one combined with GI grade 3 toxicity. A PSA doubling time ≤6 months at salvage, a Gleason score >7, and a PSA nadir ≥0.1 ng/mL predicted a worse outcome. CONCLUSION Reirradiation with EBRT for locally recurrent PCa after primary curative radiation therapy is clinically feasible and demonstrated a favorable outcome with acceptable toxicity in this prospective study with long-term follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsSalvage TherapyNeoplasm Recurrence, LocalRe-IrradiationHumansMaleAgedProspective StudiesMiddle AgedFollow-Up StudiesProstate-Specific AntigenAged, 80 and over

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
  • Department of Radiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Department of Technology and Physics, Faculty of Mathematics and Natural Sciences, University of Bergen, Bergen, Norway.
  • Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Department of Urology, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Christian Ekanger, Liv Bolstad Hysing, Rune Kvåle, Alfred Honoré, Karsten Gravdal

Zitieren

APA

Ekanger, C., Helle, S. I., Reisæter, L., Hysing, L. B., Kvåle, R., Honoré, A., Gravdal, K., Pilskog, S., & Dahl, O. (2024). Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01391

Vancouver

Ekanger C, Helle SI, Reisæter L, Hysing LB, Kvåle R, Honoré A, et al. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.01391

BibTeX
@article{Ekanger2024,
  author = {Ekanger, Christian and Helle, Svein Inge and Reisæter, Lars and Hysing, Liv Bolstad and Kvåle, Rune and Honoré, Alfred and Gravdal, Karsten and Pilskog, Sara and Dahl, Olav},
  title = {Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.23.01391}
}
Kostenlos starten →